| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2000PNAS...9711256Y |
| P356 | DOI | 10.1073/PNAS.190353897 |
| P932 | PMC publication ID | 17187 |
| P698 | PubMed publication ID | 11016951 |
| P5875 | ResearchGate publication ID | 235615563 |
| P2093 | author name string | C Chang | |
| S Yeh | |||
| M Rahman | |||
| H K Lin | |||
| H Y Kang | |||
| Y C Hu | |||
| H J Ting | |||
| C L Hsu | |||
| P2860 | cites work | Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer | Q41105263 |
| An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter | Q41131631 | ||
| Characteristics of the biphasic action of androgens and of the potent antiproliferative effects of the new pure antiestrogen EM-139 on cell cycle kinetic parameters in LNCaP human prostatic cancer cells. | Q42473124 | ||
| Growth retardation and tumour inhibition by BRCA1. | Q48066075 | ||
| BRCA1 mutations in primary breast and ovarian carcinomas | Q48078473 | ||
| Androgens accelerate thymocyte apoptosis. | Q50910612 | ||
| Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor. | Q50966501 | ||
| BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells | Q60568779 | ||
| Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor | Q60594517 | ||
| Steroid hormone receptors compete for factors that mediate their enhancer function | Q61818663 | ||
| Rapid detection of BRCA1 mutations by the protein truncation test | Q62978349 | ||
| A point mutation in the second zinc finger of the DNA-binding domain of the androgen receptor gene causes complete androgen insensitivity in two siblings with receptor-positive androgen resistance | Q70513036 | ||
| Induction of immature thymocyte proliferation after castration of normal male mice | Q72693067 | ||
| Differential induction of androgen receptor transactivation by different androgen receptor coactivators in human prostate cancer DU145 cells | Q73530529 | ||
| Activation of transcription in vitro by the BRCA1 carboxyl-terminal domain | Q77801019 | ||
| Effect of p21waf1/cip1 transgene on radiation induced apoptosis in T cells | Q77918828 | ||
| Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate | Q22009024 | ||
| Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor | Q22009068 | ||
| The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator | Q22010240 | ||
| Isolation and characterization of ARA160 as the first androgen receptor N-terminal-associated coactivator in human prostate cells | Q22010448 | ||
| Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells | Q24314557 | ||
| BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A | Q24315124 | ||
| From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells | Q24682910 | ||
| Molecular Cloning of Human and Rat Complementary DNA Encoding Androgen Receptors | Q28115447 | ||
| A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 | Q28115843 | ||
| Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response | Q28140763 | ||
| Association of BRCA1 with Rad51 in mitotic and meiotic cells | Q28302118 | ||
| p53 mutations in human cancers | Q28302973 | ||
| Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity | Q28910326 | ||
| The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse | Q29618622 | ||
| Radiation-induced cell cycle arrest compromised by p21 deficiency | Q29620237 | ||
| Chromatin remodeling and activation of chromosomal DNA replication by an acidic transcriptional activation domain from BRCA1. | Q30303671 | ||
| Development of human prostate cancer models for chemoprevention and experimental therapeutics studies | Q30472075 | ||
| The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region. | Q33928807 | ||
| Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells. | Q34067036 | ||
| BRCA1 physically associates with p53 and stimulates its transcriptional activity. | Q34467604 | ||
| Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium | Q34724404 | ||
| Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancer | Q39446502 | ||
| The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell-specific. | Q40448463 | ||
| Androgen regulation of the cyclin-dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter | Q40821528 | ||
| Androgen receptor: an overview | Q41000439 | ||
| Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest | Q41026724 | ||
| Induction of growth arrest and cell death by overexpression of the cyclin-Cdk inhibitor p21 in hamster BHK21 cells | Q41064833 | ||
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| cell death | Q2383867 | ||
| P304 | page(s) | 11256-61 | |
| P577 | publication date | 2000-10-10 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells | |
| P478 | volume | 97 |
| Q43252751 | A feedback loop between the androgen receptor and a NEDD4-binding protein, PMEPA1, in prostate cancer cells |
| Q96647698 | AR phosphorylation and CHK2 kinase activity regulates IR stabilized AR-CHK2 interaction and prostate cancer survival |
| Q37091948 | ARTIK-52 induces replication-dependent DNA damage and p53 activation exclusively in cells of prostate and breast cancer origin. |
| Q24631156 | Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor |
| Q79075118 | Androgen Receptors in Prostate Cancer |
| Q34125103 | Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function |
| Q37074119 | Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory |
| Q85196164 | Androgen receptor htSNPs in relation to androgen levels and OC use in young women from high-risk breast cancer families |
| Q39243442 | Androgen receptor primes prostate cancer cells to apoptosis through down-regulation of basal p21 expression |
| Q38780007 | Androgen receptor-related diseases: what do we know? |
| Q34635727 | Androgens and mammary growth and neoplasia |
| Q28211710 | BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export |
| Q24652441 | BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells |
| Q33894431 | BRCA1 and BRCA2 mutations and treatment strategies for breast cancer |
| Q28388921 | BRCA1 and Oxidative Stress |
| Q35546588 | BRCA1 in hormone-responsive cancers |
| Q24555775 | BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor |
| Q40299288 | BRCA1 modulates xenobiotic stress-inducible gene expression by interacting with ARNT in human breast cancer cells |
| Q34064538 | BRCA1 transcriptionally regulates genes involved in breast tumorigenesis |
| Q47094315 | Baicalein suppresses the androgen receptor (AR)-mediated prostate cancer progression via inhibiting the AR N-C dimerization and AR-coactivators interaction |
| Q37690567 | Breast and prostate cancer: more similar than different. |
| Q40713411 | Breast cancer: from estrogen to androgen receptor |
| Q30496149 | Cancer biomarker discovery: the entropic hallmark |
| Q39431280 | Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate cancer cells. |
| Q36533630 | Dehydroepiandrosterone, androgens and the mammary gland |
| Q33961300 | Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4. |
| Q34546378 | Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression |
| Q35761690 | Environmental, genetic, and molecular features of prostate cancer |
| Q36382025 | Expression and function of nuclear receptor co-activator 4: evidence of a potential role independent of co-activator activity |
| Q46403948 | Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas |
| Q44912912 | Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer |
| Q37933098 | Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers |
| Q44734673 | Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A. |
| Q24291571 | Identification and characterization of a novel androgen receptor coregulator ARA267-alpha in prostate cancer cells |
| Q28366099 | Identification and characterization of a tissue-specific coactivator, GT198, that interacts with the DNA-binding domains of nuclear receptors. |
| Q38786899 | Identification of Potential Anticancer Activities of Novel Ganoderma lucidum Extracts Using Gene Expression and Pathway Network Analysis |
| Q40113425 | Impact of PSA flare-up in patients with hormone-refractory prostate cancer undergoing chemotherapy. |
| Q44835048 | Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancers |
| Q43121399 | Intrinsic disorder in PTEN and its interactome confers structural plasticity and functional versatility |
| Q38186042 | Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy. |
| Q35656832 | MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer. |
| Q35100137 | Modulation of the tumor cell death pathway by androgen receptor in response to cytotoxic stimuli |
| Q92155990 | Mutational analysis of BRCA1 and BRCA2 genes in women with familial breast cancer from different regions of Colombia |
| Q34348715 | New complexities for BRCA1 and BRCA2. |
| Q28511501 | Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase |
| Q37443351 | Profiling of Cross-Functional Peptidases Regulated Circulating Peptides in BRCA1 Mutant Breast Cancer. |
| Q39702932 | Proteasomal degradation unleashes the pro-death activity of androgen receptor |
| Q44065000 | Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells |
| Q42969500 | RETRACTED: Dysregulation of cell cycle related genes and microRNAs distinguish the low- from high-risk of prostate cancer |
| Q35134266 | Research resource: EPSLiM: ensemble predictor for short linear motifs in nuclear hormone receptors. |
| Q37388507 | Subfertility and defective folliculogenesis in female mice lacking androgen receptor |
| Q30816464 | Suppression of androgen receptor transactivation by Pyk2 via interaction and phosphorylation of the ARA55 coregulator |
| Q28265036 | Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cells |
| Q24300794 | Suppression of estrogen receptor-mediated transcription and cell growth by interaction with TR2 orphan receptor |
| Q40556494 | Suppression versus induction of androgen receptor functions by the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer LNCaP cells with different passage numbers. |
| Q24817047 | T:G mismatch-specific thymine-DNA glycosylase (TDG) as a coregulator of transcription interacts with SRC1 family members through a novel tyrosine repeat motif |
| Q28188710 | T:G mismatch-specific thymine-DNA glycosylase potentiates transcription of estrogen-regulated genes through direct interaction with estrogen receptor alpha |
| Q37513919 | The Correlation Between PARP1 and BRCA1 in AR Positive Triple-negative Breast Cancer |
| Q64245953 | The Role of Androgen Receptor Signaling in Ovarian Cancer |
| Q24797305 | The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers |
| Q34318315 | The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity. |
| Q38363646 | The androgen receptor interacts with multiple regions of the large subunit of general transcription factor TFIIF. |
| Q33652431 | The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells |
| Q27014101 | The convergence of DNA damage checkpoint pathways and androgen receptor signaling in prostate cancer |
| Q86940521 | The expression and evaluation of androgen receptor in human renal cell carcinoma |
| Q33495401 | The ordering of expression among a few genes can provide simple cancer biomarkers and signal BRCA1 mutations |
| Q38003702 | The pharmacogenomics of sex hormone metabolism: breast cancer risk in menopausal hormone therapy |
| Q39471098 | The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cells. |
| Q34147026 | The wedelolactone derivative inhibits estrogen receptor-mediated breast, endometrial, and ovarian cancer cells growth |
| Q33373567 | Transcription factor and microRNA regulation in androgen-dependent and -independent prostate cancer cells |
| Q34109373 | Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner |
Search more.